Kalvista Net Income from 2010 to 2024
| KALV Stock | USD 10.06 0.03 0.30% |
Net Loss | First Reported 2013-10-31 | Previous Quarter -44.6 M | Current Value -40.4 M | Quarterly Volatility 11.2 M |
Check Kalvista Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kalvista Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 424 K, Interest Expense of 0.0 or Selling General Administrative of 4.9 M, as well as many indicators such as Price To Sales Ratio of 46.33, Dividend Yield of 0.0 or Days Sales Outstanding of 268. Kalvista financial statements analysis is a perfect complement when working with Kalvista Pharmaceuticals Valuation or Volatility modules.
Kalvista | Net Income |
Latest Kalvista Pharmaceuticals' Net Income Growth Pattern
Below is the plot of the Net Income of Kalvista Pharmaceuticals over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Kalvista Pharmaceuticals financial statement analysis. It represents the amount of money remaining after all of Kalvista Pharmaceuticals operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Kalvista Pharmaceuticals' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kalvista Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (126.64 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Kalvista Net Income Regression Statistics
| Arithmetic Mean | (31,582,067) | |
| Coefficient Of Variation | (109.32) | |
| Mean Deviation | 25,089,964 | |
| Median | (20,816,000) | |
| Standard Deviation | 34,526,172 | |
| Sample Variance | 1192.1T | |
| Range | 124.6M | |
| R-Value | (0.75) | |
| Mean Square Error | 556.9T | |
| R-Squared | 0.57 | |
| Significance | 0 | |
| Slope | (5,809,254) | |
| Total Sum of Squares | 16688.8T |
Kalvista Net Income History
Other Fundumenentals of Kalvista Pharmaceuticals
| Net Income Applicable To Common Shares | ||
| Net Income From Continuing Ops | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Kalvista Pharmaceuticals Net Income component correlations
About Kalvista Pharmaceuticals Financial Statements
Kalvista Pharmaceuticals investors use historical fundamental indicators, such as Kalvista Pharmaceuticals' Net Income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Kalvista Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Loss | -126.6 M | -24.8 M | |
| Net Loss | -24.8 M | -26.1 M | |
| Net Loss | -126.6 M | -24.8 M | |
| Net Loss | (3.44) | (6.17) | |
| Net Income Per E B T | 0.94 | 1.01 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Kalvista Stock Analysis
When running Kalvista Pharmaceuticals' price analysis, check to measure Kalvista Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kalvista Pharmaceuticals is operating at the current time. Most of Kalvista Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kalvista Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kalvista Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kalvista Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.